Preview Company (Stock code) Date/time Event Presenter
Open Orphan - £6.2m Influenza human challenge study contract win
OPEN ORPHAN (ORPH) Fri, 05 Aug 2022 07:05 am (UK time) Open Orphan - £6.2m Influenza human challenge study contract win Yamin 'Mo' Khan - Chief Executive Officer
Poolbeg Pharma - POLB 001 Announcement
OPEN ORPHAN (ORPH) Mon, 18 Jul 2022 07:00 am (UK time) Poolbeg Pharma - POLB 001 Announcement Jeremy Skillington - CEO, Poolbeg Pharma
Open Orphan - hVIVO Announces Human Challenge Trial Contract
OPEN ORPHAN (ORPH) Tue, 14 Jun 2022 07:05 am (UK time) Open Orphan - hVIVO Announces Human Challenge Trial Contract Dr. Andrew Catchpole - Chief Scientist
Omicron human challenge Model Update - hVivo
OPEN ORPHAN (ORPH) Tue, 07 Jun 2022 07:05 am (UK time) Omicron human challenge Model Update - hVivo Yamin 'Mo' Khan - Chief Executive Officer
Open Orphan - Speculation update
OPEN ORPHAN (ORPH) Fri, 06 May 2022 07:05 am (UK time) Open Orphan - Speculation update Yamin 'Mo' Khan - Chief Executive Officer
Open Orphan - £5m RSV human challenge study contract win
OPEN ORPHAN (ORPH) Mon, 28 Mar 2022 09:00 am (UK time) Open Orphan - £5m RSV human challenge study contract win Yamin 'Mo' Khan - Chief Executive Officer
hVIVO - Laboratory Facilities Expansion update
OPEN ORPHAN (ORPH) Tue, 08 Mar 2022 09:00 am (UK time) hVIVO - Laboratory Facilities Expansion update Robin Rogiers - Director Clinical Delivery & Innovation, hVIVO
Open Orphan - Appointment of Chief Executive Officer
OPEN ORPHAN (ORPH) Thu, 24 Feb 2022 07:00 am (UK time) Open Orphan - Appointment of Chief Executive Officer Cathal Friel - Executive Chairman
hVIVO - Launch of New STRiVE Project
OPEN ORPHAN (ORPH) Mon, 14 Feb 2022 10:30 am (UK time) hVIVO - Launch of New STRiVE Project Adrian Wildfire - Director of Scientific & Business Strategy, hVIVO
Open Orphan - COVID-19 Characterisation Study | Dr. Andrew Catchpole
OPEN ORPHAN (ORPH) Wed, 02 Feb 2022 10:00 am (UK time) Open Orphan - COVID-19 Characterisation Study | Dr. Andrew Catchpole Dr. Andrew Catchpole - Chief Scientist
Open Orphan - COVID-19 Characterisation Study | Cathal Friel
OPEN ORPHAN (ORPH) Wed, 02 Feb 2022 10:00 am (UK time) Open Orphan - COVID-19 Characterisation Study | Cathal Friel Cathal Friel - Executive Chairman
hVIVO - New Malaria Human Challenge Model Launched
OPEN ORPHAN (ORPH) Thu, 20 Jan 2022 04:30 pm (UK time) hVIVO - New Malaria Human Challenge Model Launched Adrian Wildfire - Director of Scientific & Business Strategy, hVIVO
Open Orphan - Malaria Human Challenge Model Launched
OPEN ORPHAN (ORPH) Thu, 20 Jan 2022 01:40 pm (UK time) Open Orphan - Malaria Human Challenge Model Launched Cathal Friel - Executive Chairman
Open Orphan - £10m Influenza human challenge study contract win
OPEN ORPHAN (ORPH) Fri, 10 Dec 2021 09:06 am (UK time) Open Orphan - £10m Influenza human challenge study contract win Cathal Friel - Executive Chairman
Open Orphan - Interim results and new contract win
OPEN ORPHAN (ORPH) Mon, 20 Sep 2021 08:00 am (UK time) Open Orphan - Interim results and new contract win Cathal Friel - Executive Chairman
Open Orphan - £8.1m Asthma Human Challenge Study Contract Win
OPEN ORPHAN (ORPH) Tue, 24 Aug 2021 07:15 am (UK time) Open Orphan - £8.1m Asthma Human Challenge Study Contract Win Cathal Friel - Executive Chairman
Open Orphan - Company Update
OPEN ORPHAN (ORPH) Wed, 14 Jul 2021 12:00 pm (UK time) Open Orphan - Company Update Cathal Friel - Executive Chairman